RACURA ONCOLOGY LTD
ASX:RACPharmaceuticals, Biotechnology & Life SciencesToday’s holders own 94.3% of what they think they own, once every option and right converts.
Share count grew 15% in 24 months; 2 cash raises in 24 months; options/rights overhang 6% of shares
RACURA ONCOLOGY LTD's ordinary share count grew 15.0% between October 2024 and June 2026, its latest share-count filing, to 196M shares. Within the 24-month window, the company raised capital twice for total disclosed proceeds of A$4.2M, most recently a A$1000K placement in June 2026. Options and rights could convert into 12M new shares, representing 6.0% of the current share count, of which 1% are in the money; the nearest expiry is December 2026. The company has more than 4 quarters of funding at the recent spend rate. No proposed securities issues are currently pending.
Quick answers · 5
When did RAC last raise capital?
The last capital raise in Racura Oncology's filings is Placement of $1000k announced 4 June 2026, one of 2 cash raises in 24 months.
How much placement capacity does RAC have left?
About 94% of the 15% placement capacity left, about 6% used in 12 months (estimate). Under ASX Listing Rule 7.1 a company may place up to 15% of its shares in 12 months without shareholder approval.
How much cash does RAC have?
In its quarterly cash report for the quarter ended 30 Sept 2026, Racura Oncology reported $30.7M of cash and estimated 8.7 quarters of funding available at its current rate of spending. That is the company's own estimate.
When do RAC's options expire?
Unexercised options and rights equal 6% of Racura Oncology's shares on issue; the nearest expiry is Dec 2026.
How much has RAC's share count grown?
Racura Oncology has 196.1M shares on issue as at 28 Oct 2026, up 15.0% over 24 months according to its Appendix 2A filings.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2AThe form a company lodges to have new securities quoted on the ASX. It restates how many of each class are on issue. quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | On issue, per this filing | Source |
|---|---|---|---|---|
| 1 Sept 2026 | 3G · unquoted | RAC : ORDINARY FULLY PAID | 196.1M | Appendix 3G |
| 13 July 2026 | 3H · cancellation | RAC : ORDINARY FULLY PAID | 196.1M | Appendix 3H |
| 2 July 2026 | 3H · cancellation | RAC : ORDINARY FULLY PAID | 196.1M | Appendix 3H |
| 16 June 2026 | 2A · quoted issue | RAC : ORDINARY FULLY PAID | 196.1M | Appendix 2A |
| 11 June 2026 | 2A · quoted issue | RAC : ORDINARY FULLY PAID | 195.6M | Appendix 2A |
Securities on issue over time
Ordinary shares and every option and rights class, month by month over two years. The top edge is the fully diluted count.
Capital raises
2 cash raises in the last 24 months · 2 in the last 12 months
Forward supply
Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.
Placement capacity
How much stock a company can place without asking holders. Listing Rule 7.1 / 7.1ARule 7.1 lets a company issue up to 15% of its shares in 12 months without a shareholder vote. Rule 7.1A adds 10% for smaller companies whose holders approve it. allows 15% of ordinary securities in any 12 months, and every Appendix 3BNotice that a company proposes to issue new securities, such as a placement. The securities are not on issue until a later filing confirms it. states how much of it an issue uses.
Pending proposed issues
Options & convertible securities
At $1.51 today, 2.3M securities are in the money (1.2% of shares on issue). No more priced supply until 1.25× today’s price, which takes it to 4.7M (2.4% of shares).
- Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
| Code | Security | Type | Exercise price | Expiry | On issue | Source |
|---|---|---|---|---|---|---|
| RACAN | Options | Price-triggered | $4.77 | 3 Dec 2026 | 112k | Filing |
| RACAO | Options | Price-triggered | $2.46 | 22 June 2027 | 132k | Filing |
| RACAP | Options | Price-triggered | $3.17 | 15 Aug 2027 | 111k | Filing |
| RACAV | Options | Price-triggered | $2.92 | 31 Jan 2028 | 166k | Filing |
| RACAAB | Options | Price-triggered | $2.11 | 30 June 2028 | 1.3M | Filing |
| RACAW | Options | Price-triggered | $1.32 | 24 Oct 2028 | 308k | Filing |
| RACAT | Options | Price-triggered | $2.23 | 1 Nov 2028 | 489k | Filing |
| RACAAC | Options | Price-triggered | $2.05 | 25 Nov 2028 | 58k | Filing |
| RACAX | Options | Price-triggered | $1.45 | 29 Nov 2028 | 1.5M | Filing |
| RACAY | Options | Price-triggered | $4.25 | 29 Nov 2028 | 3.1M | Filing |
| RACAZ | Options | Price-triggered | $1.39 | 1 Dec 2028 | 440k | Filing |
| RACAAE | Options | Price-triggered | $1.67 | 30 June 2029 | 706k | Filing |
| RACAAD | Options | Price-triggered | $1.67 | 30 June 2029 | 1.7M | Filing |
| RACAAF | Options | Price-triggered | $4.69 | 24 Nov 2029 | 153k | Filing |
| — | Options | Price-triggered | $3.05 | 30 June 2030 | 1.6M | Filing |
“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column. For what expires soon across other listed companies, see the options expiry calendar.
Director dealings
| Date | Director | Type | Shares | Options | Other | Value | Source |
|---|---|---|---|---|---|---|---|
| 24 Sept 2026 | Daniel Tillett | Buy on-market | 23k | — | — | $46k | 3Y notice |
| 16 Sept 2026 | Daniel Tillett | Buy/Sell on-market | 85k | — | — | $172k | 3Y notice |
| 5 June 2026 | Dr Sergio Scrofani | Buy on-market | 11k | — | — | $30k | 3Y notice |
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 Oct 2026.